October 14, 2021
UC's Dr. Annie Brown discusses breast cancer screening recommendations for transgender patients and ways to make care more accessible and equitable.
October 25, 2021
The University of Cincinnati's Dr. Xiaoting Zhang has been awarded a patent for a novel RNA nanoparticle treatment for breast cancer.
November 29, 2021
University of Cincinnati's Dr. Robert Van Haren recently published new research that shows lung cancer surgery outcomes between former and current smokers are similar enough that smoking should not be a barrier to offering surgery.
June 14, 2022
The University of Cincinnati's Jordan Kharofa, MD, delivered a poster presentation at the American Society of Clinical Oncology annual meeting on new research on how diet and the microbiome affects young colorectal cancer patients.
June 6, 2022
The University of Cincinnati's Atsuo Sasaki and an international team of collaborators have been awarded a Human Frontier Science Program research grant to learn more about how cells migrate, with an ultimate goal of developing new treatments to prevent cancer growth and spread.
June 10, 2022
The University of Cincinnati's Pier Paolo Scaglioni, MD, has received a $1.5 million National Cancer Institute grant to continue research into the roles of the KRAS gene and lipids in lung cancer.
August 2, 2022
The University of Cincinnati's Jiajie Diao, PhD, and colleagues have published new research in the journal Nature Communications showing light-activated proteins can help normalize dysfunction within cells.
March 28, 2023
Treatment of the first patient in a clinical trial of FLASH proton therapy for cancers in the bones of the chest has been completed at the Cincinnati Children’s/University of Cincinnati Medical Center Proton Therapy Center.
April 3, 2023
University of Cincinnati researchers recently published findings in the journal Cancer that found several enriched species, associated with enhanced tumor immune response, in the microbiomes of long-term pancreatic cancer survivors.
March 21, 2023
Amanda Jackson, MD, is the site principal investigator at the University of Cincinnati for the UP-NEXT trial that is testing a new treatment for a subset of ovarian cancer patients.